The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,601–8,700 of 31,469
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0845 · Cited by 42
Serum Levels of Omentin in End-Stage Renal Disease Patients
Alçelik, A., Tosun, M., Özlü, M. F., Eroğlu, M., Aktaş, G., Kemahlı, E., Şavlı, H., & Yazıcı, M. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000338796 · Cited by 42
Sun, P. G., Wang, T., Zhou, Y., Liu, H., Jiang, H., Zhu, W., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066744 · Cited by 44
Wang, E. T., Ku, I. A., Shah, S. J., Daviglus, M. L., Schreiner, P. J., Konety, S., Williams, O. D., Siscovick, D. S., & Bibbins-Domingo, K. B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1597 · Cited by 42
Vinet, A., Karpoff, L., Walther, G., Startun, A., Obert, P., Goret, L., Dauzat, M., & Pérez‐Martin, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.206 · Cited by 42
Iorgi, N. D., Mittelman, S. D., & Gilsanz, V. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.170 · Cited by 42
Crowther, N. J., Ferris, W. F., Ojwang, P., & Rheeder, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02505.x · Cited by 42
Gentile, M., Panico, S., Rubba, F., Mattiello, A., Chiodini, P., Jossa, F., Marotta, G., Pauciullo, P., & Rubba, P. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.69 · Cited by 42
Serralde-Zúñiga, A. E., Guevara‐Cruz, M., Tovar, A. R., et al. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0431-5 · Cited by 42
Barbarroja, N., López-Pedrera, C., Garrido‐Sánchez, L., Mayas, M. D., Oliva‐Olivera, W., Bernal-López, M. R., Bekay, R. E., & Tinahones, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048155 · Cited by 44
Lloret‐Linares, C., Faucher, P., Coupaye, M., Alili, R., Green, A., Basdevant, A., Clément, K., & Poitou, C. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.228 · Cited by 42
Nakamura, K., Sakurai, M., Miura, K., Morikawa, Y., Ishizaki, M., Yoshita, K., Kido, T., Naruse, Y., & Nakagawa, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1803-z · Cited by 42
Rembeck, K., Waldenström, J., Hellstrand, K., Nilsson, S., Nyström, K., Martner, A., Lindh, M., Norkrans, G., Westin, J., Pedersen, C., et al. (2014) · Hepatology · doi:10.1002/hep.27009 · Cited by 42
Hyperhomocysteinemia induces insulin resistance in male Sprague–Dawley rats
Golbahar, J., Aminzadeh, M. A., Kassab, S. E., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.026 · Cited by 42
Kondaki, K., Grammatikaki, E., Jiménez‐Pavón, D., Μanios, Y., González‐Gross, M., Sjöstróm, M., Gottrand, F., Molnár, D., Moreno, L. A., Kafatos, A., et al. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1322-4 · Cited by 42
Bhatt, S. P., Nigam, P., Misra, A., Guleria, R., Luthra, K., Jain, S. K., & Pasha, M. A. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040977 · Cited by 43
Gower, B., Pollock, N. K., Casazza, K., Clemens, T., Goree, L. L. T., & Granger, W. (2013) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2013-1203 · Cited by 47
Shokouhi, S., Delpisheh, A., Haghani, K., et al. (2014) · Clinical Laboratory · doi:10.7754/clin.lab.2013.130809 · Cited by 42
Haus, J. M., Solomon, T. P. J., Lŭ, L., Jesberger, J. A., Barkoukis, H. D., Flask, C. A., & Kirwan, J. P. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2011 · Cited by 42
Vitamin D status and risk of metabolic syndrome among non-diabetic young adults
Huang, C., Chang, H., Lu, C., Tseng, F., Lee, L., & Huang, K. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.05.010 · Cited by 42
Peroxisome proliferator-activated receptor translational research and clinical experience
Cheatham, W. W. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28449d · Cited by 42
Poor-Quality Sleep Is Associated with Metabolic Syndrome in Korean Adults
Lee, J., Choi, Y. S., Jeong, Y.-J., Lee, J., Kim, J., Kim, S. H., Joe, S.-H., & Jeon, T. H. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.231.281 · Cited by 41
Preclinical Atherosclerosis in Patients with Prolactinoma
Arslan, M. S., Topaloğlu, O., Şahi̇n, M., Tutal, E., Güngüneş, A., Çakır, E., Ozturk, U. İ., Karbek, B., Uçan, B., Giniş, Z., et al. (2013) · Endocrine Practice · doi:10.4158/ep13173.or · Cited by 42
Impact of lifestyle on metabolic syndrome in apparently healthy people
Buscemi, S., Sprini, D., Grosso, G., Galvano, F., Nicolucci, A., Lucisano, G., Massenti, F. M., Amodio, E., & Rini, G. B. (2014) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-014-0117-4 · Cited by 42
Fernández‐Real, J. M., García‐Fuentes, E., Moreno‐Navarrete, J. M., Murri, M., Garrido‐Sánchez, L., Ricart, W., & Tinahones, F. J. (2009) · Obesity · doi:10.1038/oby.2009.266 · Cited by 42
Nigam, A., Frasure‐Smith, N., Lespérance, F., & Julien, P. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.008 · Cited by 42
Relação entre a leptina, a massa corporal e a síndrome metabólica numa amostra da população adulta
Martins, M. D. C., Faleiro, L. L., & Fonseca, A. (2012) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.08.002 · Cited by 42
Guerra, J. F. D. C., Maciel, P. S., de Abreu, I. C. M. E., Pereira, R. R., Silva, M., Cardoso, L. D. M., Pinheiro-Sant’Ana, H. M., de Lima, W. G., Silva, M. E., & Pedrosa, M. L. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.025 · Cited by 43
Choi, M., Ryu, R., Seo, Y., Jeong, T., Shin, D., Park, Y. B., Kim, S. R., & Jung, U. J. (2014) · Food & Function · doi:10.1039/c4fo00199k · Cited by 42
Choi, H., Jeong, S.-M., Huh, G. H., & Kim, J.-I. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0036-9 · Cited by 42
Morita, S., Neto, D. D. S., Morita, F. H. A., Morita, N. K., & Lobo, S. M. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1696-5 · Cited by 42
Montes, V. N., Turner, M. S., Subramanian, S., Ding, Y., Hayden-Ledbetter, M. S., Slater, S., Goodspeed, L., Wang, S., Omer, M., den Hartigh, L. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067709 · Cited by 42
Low-grade inflammation in overweight and obese adults is affected by weight loss program
Petelin, A., Bizjak, M., Černelič-Bizjak, M., Jurdana, M., Jakus, T., & Pražnikar, Z. J. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0102-9 · Cited by 43
Pedersen, M., Pedersen, K. K., Brüünsgaard, H., Krabbe, K. S., Thomsen, C., Færch, K., Pedersen, B. K., & Mortensen, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051132 · Cited by 42
Murri, M., Alcázar-Ramírez, J., Garrido‐Sánchez, L., Linde, F., Alcaide, J., Cardona, F., & Tinahones, F. J. (2009) · Translational research · doi:10.1016/j.trsl.2009.06.001 · Cited by 42
Varol, E., Akçay, S., Özaydın, M., Erdoğan, D., Doğan, A., & Altınbaş, A. (2010) · Journal of Cardiology · doi:10.1016/j.jjcc.2010.03.005 · Cited by 42
Common PCSK1 Haplotypes Are Associated With Obesity in the Chinese Population
Chang, Y., Chiu, Y., Shih, K., Lin, M., Sheu, W. H., Donlon, T. A., Curb, J. D., Jou, Y., Chang, T., Li, H., et al. (2009) · Obesity · doi:10.1038/oby.2009.390 · Cited by 43
Chen, G., Liu, C., Yao, J. Y., Jiang, Q., Chen, N., Huang, H., Liang, J., Li, L., & Lin, L. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.009 · Cited by 42
Assessment of Insulin Resistance and Metabolic Syndrome in Drug Naive Patients of Bipolar Disorder
Guha, P., Bhowmick, K., Mazumder, P., Ghosal, M. K., Chakraborty, I., & Burman, P. (2013) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0292-x · Cited by 42
Epicardial adipose tissue, hepatic steatosis and obesity
Çıkım, A. S., Topal, E., Harputluoglu, M. M. M., Keskin, L., Zengin, Z., Cikim, K., Оздемир, Р., Aladağ, M. A., & Yoloğlu, S. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346328 · Cited by 41
Nolan, J. J., & Færch, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2684-0 · Cited by 44
Moon, J. H., Lim, S. K., Han, J. W., Kim, K. M., Choi, S. H., Park, K. S., Kim, K. W., & Jang, H. C. (2015) · Stroke · doi:10.1161/strokeaha.114.008170 · Cited by 44
de Guevara, A. L., Otta, C. F., Crisosto, N., de Mereshian, P. S., Echiburú, B., Iraci, G. S., Pérez‐Bravo, F., & Sir‐Petermann, T. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.020 · Cited by 44
Bloomer, R. J., Fisher‐Wellman, K. H., & Tucker, P. S. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-25 · Cited by 42
Ding, W., Yan, Y., Zhang, M. X., Cheng, H., Zhao, X., Hou, D., & Mi, J. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.124 · Cited by 42
Serum Leptin Level is Reduced in Non-Obese Subjects with Type 2 Diabetes
Mohammadzadeh, G., & Zarghami, N. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.6535 · Cited by 42
Thorseng, T., Witte, D. R., Vistisen, D., Borch‐Johnsen, K., Bjerregaard, P., & Jørgensen, M. E. (2009) · International Journal of Circumpolar Health · doi:10.3402/ijch.v68i4.17373 · Cited by 43
Heritability and genetic correlations of insulin sensitivity measured by the euglycaemic clamp
Rasmussen‐Torvik, L. J., Pankow, J. S., Jacobs, D. R., Steffen, L. M., Moran, A. M., Steinberger, J., & Sinaiko, A. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02271.x · Cited by 41
Pham, T., Ekwaru, J. P., Setayeshgar, S., et al. (2015) · Nutrients · doi:10.3390/nu7095338 · Cited by 42
Kardassis, D., Bech‐Hanssen, O., Schönander, M., Sjöström, L., & Karason, K. (2011) · Obesity · doi:10.1038/oby.2011.101 · Cited by 42
Khalyfa, A., Bhushan, B., Hegazi, M., Kim, J., Gozal, D., Bhattacharjee, R., Capdevila, Ó. S., & Gozal, D. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-18 · Cited by 42
Health Inequalities in Urban Adolescents: Role of Physical Activity, Diet, and Genetics
Ortega, F. B., Ruiz, J. R., Labayen, I., Martínez‐Gómez, D., Vicente‐Rodríguez, G., Cuenca‐García, M., Gracia‐Marco, L., Μanios, Y., Béghin, L., Molnár, D., et al. (2014) · PEDIATRICS · doi:10.1542/peds.2013-1665 · Cited by 43
Biomarkers of Alzheimer Disease, Insulin Resistance, and Obesity in Childhood
Luciano, R., Barraco, G. M., Muraca, M., Ottino, S., Spreghini, M. R., Sforza, R. W., Rustico, C., Morino, G. S., & Manco, M. (2015) · PEDIATRICS · doi:10.1542/peds.2014-2391 · Cited by 44
Sulistyoningrum, D. C., Gašević, D., Lear, S. A., Ho, J. H., Mente, A., & Devlin, A. M. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-170 · Cited by 42
Ferrara, L. A., Wang, H., Umans, J. G., Franceschini, N., Jolly, S., Lee, E. T., Yeh, J., Devereux, R. B., Howard, B. V., & SIMONE, G. D. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.06.002 · Cited by 43
Taniguchi-Fukatsu, A., Yamanaka‐Okumura, H., Naniwa-Kuroki, Y., Nishida, Y., Yamamoto, H., Taketani, Y., & Takeda, E. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004156 · Cited by 43
Rosenfield, R. L., Ehrmann, D. A., & Littlejohn, E. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4290 · Cited by 42
Knops, M., Werner, C. G., Scherbakov, N., Fiebach, J. B., Dreier, J. P., Meisel, A., Heuschmann, P. U., Jungehülsing, G., von Haehling, S., Dirnagl, U., et al. (2013) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-013-0103-0 · Cited by 42
de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., Izaola, O., Castrillón, J. L. P., & Dueñas, A. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.01.017 · Cited by 42
Premilovac, D., Bradley, E. A., Ng, H., Richards, S. M., Rattigan, S., & Keske, M. A. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt015 · Cited by 42
Ichikawa, R., Daimon, M., Miyazaki, T., Kawata, T., Miyazaki, S., Maruyama, M., Chiang, S.-J., Suzuki, H., Ito, C., Sato, F., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-38 · Cited by 43
Christopher, B. A., Huang, H., Berthiaume, J. M., McElfresh, T. A., Chen, X., Croniger, C. M., Muzic, R. F., & Chandler, M. P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00687.2010 · Cited by 43
Karrowni, W., Li, Y., Jones, P. G., Cresci, S., Abdallah, M., Lanfear, D. E., Maddox, T. M., McGuire, D. K., Spertus, J. A., & Horwitz, P. A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301585 · Cited by 42
Ohkura, T., Fujioka, Y., Nakanishi, R., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-106 · Cited by 42
Lekva, T., Bollerslev, J., Godang, K., Roland, M. C. P., Friis, C. M., Voldner, N., Henriksen, T., & Ueland, T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0153 · Cited by 42
Rasmussen, M. H., Juul, A., Kjems, L., & Hilsted, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02246 · Cited by 42
Impact of Body Mass Index on the Risk of Colorectal Adenoma in a Metabolically Healthy Population
Yun, K. E., Chang, Y., Jung, H.-S., Kim, C., Kwon, M., Park, S. K., Sung, E., Shin, H. C., Park, H. S., & Ryu, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3477 · Cited by 42
Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren
Pedrosa, C. A., Oliveira, B. M. P. M., Albuquerque, I., et al. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-40 · Cited by 42
Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype
Jenkinson, C. P., Göring, H. H. H., Arya, R., Blangero, J., Duggirala, R., & DeFronzo, R. A. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.12.001 · Cited by 45
Gómez-Arbeláez, D., Camacho, P. A., Cohen, D. D., Saavedra-Cortes, S., Lopez-Lopez, C., & López-Jaramillo, P. A. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0566-1 · Cited by 43
Wolf, R. M., Steele, K. E., Frame, L. A., Zeng, X., Jaffe, A. E., Schweitzer, M., Magnuson, T. H., & Wong, G. W. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1027 · Cited by 44
The Effects of Fetal Gender on Maternal and Fetal Insulin Resistance
Walsh, J., Segurado, R., Mahony, R. M., Foley, M. E., & McAuliffe, F. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137215 · Cited by 42
Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes
Aung, L., Lee, W., Chen, S. C., Ser, K., Wu, C., Chong, K., Lee, Y.-C., & Chen, J. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.1130 · Cited by 43
Gómez-Zamudio, J. H., Mendoza‐Zubieta, V., Ferreira‐Hermosillo, A., Molina-Ayala, M., Valladares‐Salgado, A., Suárez‐Sánchez, F., Peralta‐Romero, J., & Cruz, M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.10.007 · Cited by 42
Kanuri, B., Kanshana, J. S., Rebello, S. C., Pathak, P., Gupta, A. P., Gayen, J. R., Jagavelu, K., & Dikshit, M. (2017) · Scientific Reports · doi:10.1038/srep41009 · Cited by 40
Li, N., Yan, W., Hu, X., Huang, Y., Wang, F., Zhang, W., Wang, Q., Wang, X., & Sun, K.-H. (2017) · Clinical Endocrinology · doi:10.1111/cen.13303 · Cited by 45
Garabadu, D., & Krishnamurthy, S. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1268635 · Cited by 42
Umegaki, H., Makino, T., Uemura, K., Shimada, H., Hayashi, T., Cheng, X. W., & Kuzuya, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00072 · Cited by 42
Alonso-Álvarez, M. L., Téran‐Santos, J., Martinez, M. G., Cordero-Guevara, J. A., Jurado, M. J., Corral‐Peñafiel, J., Durán‐Cantolla, J., Carbajo, E. O., Masa, F., Gozal, D., et al. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.06.002 · Cited by 41
Association between cytokines and liver histology in children with nonalcoholic fatty liver disease
Perito, E. R., Ajmera, V. H., Bass, N. M., Rosenthal, P. J., Lavine, J. E., Schwimmer, J. B., Yates, K. P., Diehl, A. M., Molleston, J. P., Murray, K. F., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1068 · Cited by 42
Modifiable Lifestyle Risk Factors and Incident Diabetes in African Americans
Joseph, J. J., Echouffo-Tcheugui, J. B., Talegawkar, S. A., Effoe, V. S., Okhomina, V. I., Carnethon, M. R., Hsueh, W. A., & Golden, S. H. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.018 · Cited by 43
Gandhi, S. R., Gandhi, G. R., Denadai, M., Sridharan, G., Jothi, G., Ponnusamy, S., Quintans, J. D. S. S., Narain, N., Cuevas, L. E., Coutinho, H. D. M., et al. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.03.050 · Cited by 42
Kuo, C., Su, P., Sun, C.-W., Liu, H., Chang, C., & Wang, S. (2018) · Environment International · doi:10.1016/j.envint.2018.05.033 · Cited by 43
Role of wnt5a in Metabolic Inflammation in Humans
Relling, I., Akcay, G., Fangmann, D., Knappe, C., Schulte, D. M., Hartmann, K., Müller, N., Türk, K., Dempfle, A., Franke, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01007 · Cited by 44
Watanabe, M., Masieri, S., Costantini, D., Tozzi, R., Giorgi, F. D., Gangitano, E., Tuccinardi, D., Poggiogalle, E., Mariani, S., Basciani, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202683 · Cited by 42
Human C-reactive protein aggravates osteoarthritis development in mice on a high-fat diet
Kozijn, A. E., Tartjiono, M. T., Ravipati, S., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.09.007 · Cited by 42
Azizian, H., Khaksari, M., Asadikaram, G., Esmailidehaj, M., & Farhadi, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.028 · Cited by 43
Liakos, A., Lambadiari, V., Bargiota, Α., Kitsios, K., Avramidis, I., Kotsa, K., Gerou, S., Boura, P., Tentolouris, N., Dimitriadis, G., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13541 · Cited by 42
Pοlyzos, S. A., Slavakis, A., Koumerkeridis, G., Katsinelos, P., & Kountouras, J. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0713-1330 · Cited by 43
Bitar, M. S., Nader, J., Al-Ali, W., Madhoun, A. S. A., Arefanian, H., & Al‐Mulla, F. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6825452 · Cited by 41
Yim, J., Kim, G., Lee, B., Kang, E. S., Soo, B., Kim, J., Cho, J. W., Lee, S., & Lee, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00691 · Cited by 42
Ferreira, F. G., Juvanhol, L. L., da Silva, D. C. G., et al. (2018) · Public Health Nutrition · doi:10.1017/s136898001800335x · Cited by 42
Gingras, V., Rifas‐Shiman, S. L., Taveras, E. M., Oken, E., & Hivert, M. (2018) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-018-0759-0 · Cited by 42
Metwally, F. M., Rashad, H. M., & Mahmoud, A. A. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.12.010 · Cited by 42
The association between serum testosterone and insulin resistance: a longitudinal study
Ottarsdottir, K., Nilsson, A. G., Hellgren, M. I., Lindblad, U., & Daka, B. (2018) · Endocrine Connections · doi:10.1530/ec-18-0480 · Cited by 51
Henriksson, P., Sandborg, J., Blomberg, M. I., Alexandrou, C., Maddison, R., Silfvernagel, K., Henriksson, H., Leppänen, M. H., Migueles, J. H., Widman, L., et al. (2019) · JMIR Research Protocols · doi:10.2196/13011 · Cited by 45
Siddiqui, A. A., Desai, N. G., Sharma, S. B., Aslam, M., Sinha, U. K., & Madhu, S. V. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3147 · Cited by 42
Huh, J. H., Ahn, S. G., Kim, Y. I., Go, T., Sung, K., Choi, J. H., Koh, K. K., & Kim, J. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0111 · Cited by 40
Levine, C. S., Markus, H. R., Austin, M. K., Chen, E., & Miller, G. E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812068116 · Cited by 41
Falcone, V., Kotzaeridi, G., Breil, M. H., Rosicky, I., Linder, T., Yerlikaya‐Schatten, G., Feichtinger, M., Eppel, W., Husslein, P. W., Tura, A., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0218 · Cited by 45
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
